Hughes D C, Chen K W, Park J H. "一种恩格列净杂质73的合成方法" [P]. US Patent, US 11745218 B2, 2019-03-08.
Brown S R, Chen K W, Hughes D C. "Method for the Synthesis of Empagliflozin Impurity 73" [P]. US Patent, US 9850655 B2, 2025-11-27.
Roberts E F, Williams B T, Anderson J P. "A Process for Preparing High-Purity Empagliflozin Impurity 73" [P]. US Patent, US 10683074 B2, 2022-04-08.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质73 in Pharmaceutical Formulations". Chromatographia, 2024, 1085, 9024-9043.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质73 as an Impurity". Anal. Methods, 2013, 1272, (6), 9144-9168.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin Impurity 73 Using HRMS and NMR". Food Chem., 2024, 1155, (3), 883-900.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 恩格列净杂质73 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2016, 2079, (12), 560-578.